Literature DB >> 14046016

CHARACTERIZATION OF THE GROWTH INHIBITION FACTOR FOR CRYPTOCOCCUS NEOFORMANS (GIFC) IN HUMAN SERUM.

G L BAUM, D ARTIS.   

Abstract

Entities:  

Keywords:  BLOOD; CRYPTOCOCCUS; HODGKIN'S DISEASE; LEUKEMIA, LYMPHOCYTIC; MACROGLOBULINEMIA; MULTIPLE MYELOMA

Mesh:

Year:  1963        PMID: 14046016     DOI: 10.1097/00000441-196307000-00007

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


× No keyword cloud information.
  9 in total

Review 1.  Cryptococcal interactions with the host immune system.

Authors:  Kerstin Voelz; Robin C May
Journal:  Eukaryot Cell       Date:  2010-04-09

2.  Host defence to pulmonary mycosis.

Authors:  C H Mody; P W Warren
Journal:  Can J Infect Dis       Date:  1999-03

3.  Phagocytosis of Cryptococcus neoformans by alveolar macrophages.

Authors:  G S Bulmer; J R Tacker
Journal:  Infect Immun       Date:  1975-01       Impact factor: 3.441

4.  Olfactory mucosa response in guinea pigs following intranasal instillation with Cryptococcus neoformans. A histological and immunocytochemical study.

Authors:  C Lima; J P Vital
Journal:  Mycopathologia       Date:  1994-05       Impact factor: 2.574

5.  Characterization of an anticryptococcal protein isolated from human serum.

Authors:  S Sridhar; M Ahluwalia; E Brummer; D A Stevens
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

6.  Study of the role of iron in the anticryptococcal activity of human serum and fluconazole.

Authors:  D D Grover; E Brummer; D A Stevens
Journal:  Mycopathologia       Date:  1996       Impact factor: 2.574

Review 7.  Immunity in cryptococcosis: an overview.

Authors:  R A Fromtling; H J Shadomy
Journal:  Mycopathologia       Date:  1982-03-19       Impact factor: 2.574

8.  Immunological studies of the anticryptococcal factor of normal human serum.

Authors:  F Reiss; G Szilagyi; E Mayer
Journal:  Mycopathologia       Date:  1975-06-14       Impact factor: 2.574

9.  Intracellular fate of Cryptococcus neoformans.

Authors:  J R Tacker; F Farhi; G S Bulmer
Journal:  Infect Immun       Date:  1972-08       Impact factor: 3.441

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.